Clinical trials
Recurrence trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 6 |
| Unknown status | 6 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| Hospices Civils de Lyon | 3 |
| Centre Leon Berard | 2 |
| Institut Cancerologie de l'Ouest | 2 |
| University Hospital, Bordeaux | 2 |
| AGO Study Group | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Henri Becquerel | 1 |
| Centre Hospitalier Charles Perrens, Bordeaux | 1 |
| Centre Hospitalier Henri Laborit | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 36 |
| Alcoholism | 3 |
| Carcinoma, Hepatocellular | 2 |
| Crohn Disease | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Anxiety Disorders | 1 |
| Asthma | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.